In addition, our successful generation of a transgenic marmoset disease model with abnormal protein accumulation and neurodegeneration paves the way for the establishment of gene-modified marmoset models of other neurodegenerative diseases in general, not limited to SCA3. This evidence concerns the gene ATXN3 and neurodegenerative disease.